STARD7 and cholangiocarcinoma: STARD7 was overexpressed in many human tumors, including cholangiocarcinoma (CHOL), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), diffuse large B cell lymphoma (DLBCL), glioblastoma (GBM), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), skin cutaneous melanoma (SKMC), testicular germ cells tumor (TGCT), thymoma (THYM), and breast cancer (BRCA), as indicated by data generated by the TCGA Research Network (https://www.cancer.gov/tcga) (Figure1A).